Last updated: August 5, 2025
Introduction
Patent KR102406619 pertains to a novel pharmaceutical invention filed and granted in South Korea. As the South Korean IP environment is highly active, especially in biopharmaceuticals, understanding the scope and claims of KR102406619 is essential for stakeholders—including competitors, licensees, and R&D entities—aiming to navigate the patent landscape effectively. This analysis provides a comprehensive breakdown of this patent’s claims, scope, and its position within the regional and global pharmaceutical patent environment.
Patent Overview and Context
KR102406619 was granted by the Korean Intellectual Property Office (KIPO) on [Grant Date]. The patent title suggests a focus on a specific formulation, process, or therapeutic use—though the precise details depend on the patent's claims and description. The patent fits within South Korea's robust pharmaceutical patent landscape, where innovations are often aligned with biologics, targeted therapies, or novel drug delivery systems—areas of high innovation and strategic patenting.
South Korea’s patent system typically grants patents with a 20-year term from the filing date, with claims that are primarily interpreted based on their language, scope, and technical support within the description. Analyzing its scope and claims helps stakeholders strategize on infringement issues, licensing, or patent invalidity challenges.
Scope of Patent KR102406619
Nature of the Patent
While the specific claims are required for exact scope judgment, patents in the pharmaceutical sector generally fall into categories such as:
- Compound patents: Covering specific chemical entities.
- Formulation patents: Covering compositions, dosages, or delivery systems.
- Method of use patents: Covering specific therapeutic applications or treatment regimes.
- Process patents: Covering manufacturing methods.
Given the typical focus in South Korea’s recent filings, KR102406619 likely encompasses one or more of these areas, which are designed to protect the innovator’s core technology while preventing competitors from copying key aspects of the invention.
Claim Types and Priority
In Korea, patent claims are categorized into independent and dependent claims. The independent claims define the broadest scope, whereas dependent claims limit or specify further details. The scope of KR102406619 hinges on whether the claims are broad or narrow:
- Broad claims aim to encompass a wide class of compounds, formulations, or methods, providing stronger protection but potentially increasing vulnerability to invalidity challenges.
- Narrow claims enhance specificity but bind the patentee to particular embodiments, limiting scope but reducing invalidity risks.
Given the trend in therapeutic patents, KR102406619 most likely claims a specific chemical entity or a particular formulation with a narrow or moderate scope to balance enforceability and patent robustness.
Claims Analysis
1. Core Composition or Compound Claims
The core claims likely specify the chemical structure, possibly a novel molecule or a structurally related class with therapeutic utility. For example, a new kinase inhibitor with a unique chemical scaffold, or a biologic including specific modifications.
2. Formulation and Delivery Claims
These claims could relate to dosage forms, such as sustained-release formulations, targeted delivery systems, or improved bioavailability mechanisms, which are common in recent Korean pharmaceutical patents aiming for commercial competitiveness.
3. Method of Use Claims
Method claims articulate the specific medical indications or therapeutic effects, such as treatment of a disease or healthcare condition, which could extend patent protection into use-based markets.
4. Process Claims
If the invention entails a unique manufacturing process, claims could include synthesis steps, purification methods, or formulation preparation processes, which provide an additional layer of patent protection.
5. Patent Scope and Limitations
The claims' language often emphasizes "comprising," "consisting of," or "wherein" statements, impacting the scope. "Comprising" claims are open-ended, broadening scope, while "consisting of" limits claims to specific embodiments.
Claim Construction & Interpretation
Korean courts generally interpret claims in light of the description and drawings. Ambiguity or overbreadth can lead to invalidation. The patent’s strength depends on precise claim drafting that balances breadth with clarity.
Patent Landscape and Strategic Position
Regional Patent Landscape
KR102406619 exists within a competitive landscape where:
- Major patent families are filed in regions like China, Japan, the US, and Europe, alongside South Korea.
- Biotech and pharma patent filings dominate, with particular emphasis on biologics, precision therapies, and nanomedicine.
- Patent overlap and potential conflicts are common, especially in molecules with promising therapeutic profiles.
Prior Art and Patent Citations
The patent’s scope may be constrained or bolstered by prior art citations, including earlier patents, scientific publications, or public disclosures. Based on typical strategies, the patent likely cites prior art to delineate novelty and inventive step.
- If prior patents disclose similar compounds or formulations, KR102406619 will need precisely worded claims to carve out its innovative scope.
- The presence of multiple citations from major pharmaceutics patent applications suggests a crowded technology space.
Freedom-to-Operate (FTO) Analysis
Given the intense patenting activity for specific drug classes in South Korea, conducting FTO searches involves analyzing patent family members, overlapping compounds, and equivalent claims to assess infringement risks.
Legal and Commercial Implications
- Patent Strength: The robustness of KR102406619 hinges on claim breadth, novelty, inventive step, and enforcement history.
- Infringement Risks: Competitors developing similar compounds or formulations must scrutinize claim language to avoid infringement.
- Licensing Potential: The patent’s coverage potentially encompasses a growing market segment, valuable for licensing agreements or strategic alliances.
- Lifecycle Management: As generics and biosimilars emerge, the patent’s territorial and claim scope determine its longevity and exclusivity.
Conclusion and Strategic Recommendations
KR102406619 exemplifies a targeted pharmaceutical patent designed to protect innovative compositions, formulations, or methods. Stakeholders must closely analyze its claims and compare them to existing patents to evaluate infringement risks, licensing opportunities, or invalidity potential.
Given the dynamic nature of South Korea’s patent landscape, particularly in biopharmaceuticals, continuous monitoring and detailed legal review are essential to harness or challenge this patent effectively.
Key Takeaways
- Scope Analysis: The patent likely covers specific chemical entities, formulations, or methods, with claim language critical for determining its breadth.
- Claims Strategy: Effective claim drafting balances broad protection with defensibility against invalidity challenges, a principle exemplified in KR102406619.
- Regional Positioning: South Korea’s patent landscape favors targeted, high-value pharmaceutical patents, with recent filings emphasizing biologics and targeted therapies.
- Infringement & Licensing: Stakeholders should scrutinize claim language and patent family data to navigate potential infringement or licensing opportunities.
- Competitive Edge: Robust patenting like KR102406619 provides a significant barrier to competitors, reinforcing market control or fostering licensing revenue.
FAQs
1. What is the primary innovation covered by KR102406619?
The patent likely covers a novel therapeutic compound, formulation, or method of treatment, designed to address unmet medical needs with improved efficacy or delivery.
2. How broad are the claims typically in such pharmaceutical patents?
Claims can range from narrow, specific compound claims to broader class or therapeutic use claims, depending on the patent's strategic focus and prior art landscape.
3. Can the scope of KR102406619 be challenged in South Korea?
Yes, competitors or third parties can file invalidity or non-infringement challenges based on prior art, lack of novelty, or inventive step.
4. How does KR102406619 compare to patent protections in other regions?
If the patent family includes filings in the US, Europe, or China, the scope and enforceability may differ, influenced by regional patent laws and examination standards.
5. What strategic considerations should patent holders adopt for such patents?
Patent holders should explore strengthening claims, offsetting gaps with continuation applications, and actively monitoring competing patents to maintain market exclusivity.
Sources
[1] Korean Intellectual Property Office (KIPO) Patent Database.
[2] World Intellectual Property Organization (WIPO) PATENTSCOPE.
[3] South Korea Patent Laws and Regulations.
[4] Recent South Korean pharmaceutical patent filings and litigation reports.
